ENHANCED IMMUNOGENICITY OF LEUCINE-ENKEPHALIN FOLLOWING COUPLING TO ANTIIMMUNOGLOBULIN AND ANTI-CD3 ANTIBODIES

被引：0
|
作者：
HENDRICKSON, TL
WILSON, GS
FRAZER, JM
LIU, RS
MCCORMACK, RT
WOLFERT, RL
机构：
[1] UNIV KANSAS,DEPT CHEM,LAWRENCE,KS 66045
[2] HYBRITECH INC,SAN DIEGO,CA 92121
来源：
JOURNAL OF IMMUNOLOGICAL METHODS | 1994年 / 172卷 / 02期
关键词：
MONOCLONAL ANTIBODY; LEUCINE ENKEPHALIN; ANTIIMMUNOGLOBULIN; ANTI-CD3;
D O I：
10.1016/0022-1759(94)90103-1
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Leucine enkephalin (Leu-enk) was coupled to both T and B cell antibodies in order to investigate the possibility of enhanced immunogenicity via targeted immunization. The two antibodies used were Hm x Mo CD3 and Gt x Mo Ig, respectively. The data indicate that while both antibody carriers enhanced the immunogenicity of Leu-enk, the use of the Hm x Mo CD3 antibody resulted in a greater number of mice with positive Leu-enk specific serum titers. 12 Leu-enk cell lines were produced and one, LE4H8, was chosen for characterization.
引用
收藏
页码：165 / 172
页数：8
相关论文
共 50 条
  • [41] ANTI-CD2 MONOCLONAL-ANTIBODIES SYNERGIZE WITH ANTI-CD3 TO PROLONG ALLOGRAFT SURVIVAL AND DECREASE CYTOKINE PRODUCTION
    CHAVIN, KD
    QIN, L
    LIN, J
    KAPLAN, AJ
    BROMBERG, JS
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 823 - 824
  • [42] ANTI-CD4 BLOCKS THE IMMUNE-RESPONSE TO ANTI-CD3 MONOCLONAL-ANTIBODIES, BUT DOES NOT BLOCK THE TOXICITY
    FINCK, BK
    YUNG, C
    CARTERON, N
    SEAMAN, WE
    WOFSY, D
    CLINICAL RESEARCH, 1991, 39 (01): : A56 - A56
  • [43] Gene expression profile of human T cells following a single stimulation of peripheral blood mononuclear cells with anti-CD3 antibodies
    Sousa, Isabel Garcia
    Rodrigues Simi, Kelly Cristina
    do Almo, Manuela Maragno
    Andressa Gomes Bezerra, Maryani
    Doose, Gero
    Raiol, Taina
    Stadler, Peter F.
    Hoffmann, Steve
    Maranhao, Andrea Queiroz
    Brigido, Marcelo Macedo
    BMC GENOMICS, 2019, 20 (1)
  • [44] Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: Evidence for an IL-4 requirement
    Punch, JD
    Tono, T
    Qin, LH
    Bishop, DK
    Bromberg, JS
    JOURNAL OF IMMUNOLOGY, 1998, 161 (03): : 1156 - 1162
  • [45] Effects of an FcγRIIA polymorphism on leukocyte gene expression and cytokine responses to anti-CD3 and anti-CD28 antibodies
    Michelle M. Stein
    Cara L. Hrusch
    Anne I. Sperling
    Carole Ober
    Genes & Immunity, 2019, 20 : 462 - 472
  • [46] Effects of an FcγRIIA polymorphism on leukocyte gene expression and cytokine responses to anti-CD3 and anti-CD28 antibodies
    Stein, Michelle M.
    Hrusch, Cara L.
    Sperling, Anne, I
    Ober, Carole
    GENES AND IMMUNITY, 2019, 20 (06) : 462 - 472
  • [47] ACTIVATION OF RESTING LYMPHOCYTES-T BY ANTI-CD3 (T3) ANTIBODIES IN THE ABSENCE OF MONOCYTES
    TSOUKAS, CD
    LANDGRAF, B
    BENTIN, J
    VALENTINE, M
    LOTZ, M
    VAUGHAN, JH
    CARSON, DA
    JOURNAL OF IMMUNOLOGY, 1985, 135 (03): : 1719 - 1723
  • [48] THERAPEUTIC INTEREST OF ANTI-CD3 AND ANTI-BAFF MONOCLONAL ANTIBODIES IN THE NOD MODEL OF SJOGREN'S SYNDROME
    Felten, R.
    Chatenoud, L.
    Magne, L.
    Sawaf, M.
    Seifert, C.
    Dumortier, H.
    Monneaux, F.
    Sibilia, J.
    Schneider, P.
    Gottenberg, J. -E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 277 - 278
  • [49] Preparation and characterization for bispecific antibodies of anti-CD3 X anti-idiotype to B cell lymphocytic leukemia
    Shen Guanxin
    Zhang Yue
    Zhu Huifen
    Yang Jing
    Wang Xiaolin
    Current Medical Science, 1999, 19 (3) : 166 - 169
  • [50] Gene expression analysis by microarray following anti-CD3 antibody therapy of NOD mice
    Iwai, Hideyuki
    Kodama, Keichi
    Dang, Demi
    Fathman, C. Garrison
    Bluestone, Jeffrey A.
    CLINICAL IMMUNOLOGY, 2007, 123 : S9 - S9
12345